In-Silico Identification of the Best Compound Against Leishmania infantum: High Throughput Screening of All FDA Approved Drugs

In-Silico Identification of the Best Compound Against Leishmania infantum: High Throughput Screening of All FDA Approved Drugs

Objective:Current in-silico research was designed and administered for the screening of 20000 Food and Drug Administration-approved drug compounds with the goal of finding promising drugs against lipophosphoglycan (LPG) and γ-glutamylcysteine synthetase (γ-GCS) of Leishmania infantum.Methods:After t...

Full description

Bibliographic Details
Main Authors: Jasem Saki, Farnoush Shadnoush, Reza Arjmand, Fakher Rahim
Format: Article
Language:English
Published: Galenos Yayinevi 2019-12-01
Series:Türkiye Parazitoloji Dergisi
Subjects:
in-silico
lipophosphoglycan
γ-glutamylcysteine synthetase
molecular docking
cytotoxic and anti-cancer activity
Online Access: http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/n-silico-dentification-of-the-best-compound-agains/32290

Internet

http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/n-silico-dentification-of-the-best-compound-agains/32290

Similar Items